354 related articles for article (PubMed ID: 31513035)
1. Using buprenorphine to treat patients with opioid use disorder.
Radi JK; Fogarty KJ; Lagerwey MD
JAAPA; 2019 Oct; 32(10):30-35. PubMed ID: 31513035
[TBL] [Abstract][Full Text] [Related]
2. Why 24 State and Territorial Health Officials Support Buprenorphine Deregulation.
Stancliff S; Greene D; Zucker HA
Am J Public Health; 2019 Dec; 109(12):1678-1679. PubMed ID: 31693402
[No Abstract] [Full Text] [Related]
3. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
Jones CM; McCance-Katz EF
Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
[TBL] [Abstract][Full Text] [Related]
4. Opioid use disorder and COVID-19: Implications for policy and practice.
Mitchell M; Shee K; Champlin K; Essary AC; Evans M
JAAPA; 2021 Jun; 34(6):1-4. PubMed ID: 34031321
[TBL] [Abstract][Full Text] [Related]
5. Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential.
Sigmon SC; Bigelow GE
Addiction; 2017 Mar; 112(3):386-387. PubMed ID: 27561982
[No Abstract] [Full Text] [Related]
6. What Role Should Psychiatrists Have in Responding to the Opioid Epidemic?
Muvvala SB; Edens EL; Petrakis IL
JAMA Psychiatry; 2019 Feb; 76(2):107-108. PubMed ID: 30484813
[No Abstract] [Full Text] [Related]
7. Nurse Practitioner and Physician Assistant Waivers to Prescribe Buprenorphine and State Scope of Practice Restrictions.
Spetz J; Toretsky C; Chapman S; Phoenix B; Tierney M
JAMA; 2019 Apr; 321(14):1407-1408. PubMed ID: 30964519
[TBL] [Abstract][Full Text] [Related]
8. Buprenorphine Supply, Access, and Quality: Where We Have Come and the Path Forward.
Breen CT; Fiellin DA
J Law Med Ethics; 2018 Jun; 46(2):272-278. PubMed ID: 30147002
[TBL] [Abstract][Full Text] [Related]
9. Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine.
Chou R; Ballantyne J; Lembke A
Ann Intern Med; 2019 Sep; 171(6):427-429. PubMed ID: 31450240
[No Abstract] [Full Text] [Related]
10. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
[TBL] [Abstract][Full Text] [Related]
11. The prescribing of buprenorphine by advanced practice addictions nurses.
Strobbe S; Hobbins D
J Addict Nurs; 2012 Feb; 23(1):82-3. PubMed ID: 22468667
[TBL] [Abstract][Full Text] [Related]
12. Use of Buprenorphine to Treat Opioid Use Disorder.
Bartholow LAM; Pope J
J Psychosoc Nurs Ment Health Serv; 2018 Nov; 56(11):9-12. PubMed ID: 30383881
[TBL] [Abstract][Full Text] [Related]
13. In Rural Areas, Buprenorphine Waiver Adoption Since 2017 Driven By Nurse Practitioners And Physician Assistants.
Barnett ML; Lee D; Frank RG
Health Aff (Millwood); 2019 Dec; 38(12):2048-2056. PubMed ID: 31794302
[TBL] [Abstract][Full Text] [Related]
14. Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder.
Davis CS; Carr DH; Glenn MJ; Samuels EA
Ann Emerg Med; 2021 Jul; 78(1):102-108. PubMed ID: 33781607
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine Dispensing after Elimination of the Waiver Requirement.
Chua KP; Bicket MC; Bohnert ASB; Conti RM; Lagisetty P; Nguyen TD
N Engl J Med; 2024 Apr; 390(16):1530-1532. PubMed ID: 38657250
[No Abstract] [Full Text] [Related]
16. TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19.
Pena E; Ahmed S
Addiction; 2020 Oct; 115(10):1978-1979. PubMed ID: 32447795
[No Abstract] [Full Text] [Related]
17. Perioperative Management and Analgesia for Patients Taking Buprenorphine and Other Forms of Medication-Assisted Treatment for Substance Abuse Disorders.
Scholzen E; Zeng AM; Schroeder KM
Adv Anesth; 2019 Dec; 37():65-86. PubMed ID: 31677660
[No Abstract] [Full Text] [Related]
18. Early-Career and Graduating Physicians More Likely to Prescribe Buprenorphine.
Peterson LE; Morgan ZJ; Eden AR
J Am Board Fam Med; 2020; 33(1):7-8. PubMed ID: 31907240
[TBL] [Abstract][Full Text] [Related]
19. Buprenorphine Treatment for Opioid Use Disorder: An Overview.
Shulman M; Wai JM; Nunes EV
CNS Drugs; 2019 Jun; 33(6):567-580. PubMed ID: 31062259
[TBL] [Abstract][Full Text] [Related]
20. Medications for management of opioid use disorder.
Koehl JL; Zimmerman DE; Bridgeman PJ
Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
